PubRank

Holly K Dressman

Author PubWeight™ 80.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2005 19.56
2 Retracted Genomic signatures to guide the use of chemotherapeutics. Nat Med 2006 7.45
3 Retracted A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006 6.69
4 Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2005 6.23
5 Retracted Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA 2008 3.26
6 Retracted Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 2007 2.80
7 Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 2005 2.63
8 Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res 2005 2.37
9 Gene expression patterns that characterize advanced stage serous ovarian cancers. J Soc Gynecol Investig 2004 1.68
10 Unfolded protein response genes regulated by CED-1 are required for Caenorhabditis elegans innate immunity. Dev Cell 2008 1.59
11 Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care. Breast Cancer Res Treat 2009 1.46
12 Retracted An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. PLoS One 2008 1.45
13 Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS One 2008 1.44
14 Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2. Mol Cell Biol 2008 1.42
15 Elevated expression of a subset of interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis. Leuk Res 2004 1.41
16 Distinctions in the specificity of E2F function revealed by gene expression signatures. Proc Natl Acad Sci U S A 2005 1.34
17 Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol 2004 1.29
18 Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma. Clin Cancer Res 2006 1.26
19 Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 2004 1.26
20 Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome. J Clin Oncol 2010 1.20
21 Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. Clin Cancer Res 2009 1.16
22 Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype. Gynecol Oncol 2009 1.15
23 Retracted Gene-expression patterns predict phenotypes of immune-mediated thrombosis. Blood 2005 1.12
24 Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer. Proc Natl Acad Sci U S A 2009 1.09
25 Diagnosis of partial body radiation exposure in mice using peripheral blood gene expression profiles. PLoS One 2010 1.07
26 Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma. Cancer Res 2005 1.03
27 ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression. BMC Cardiovasc Disord 2006 0.96
28 Retraction: Genomic signatures to guide the use of chemotherapeutics. Nat Med 2011 0.94
29 Gene expression profiles of the rat brain both immediately and 3 months following acute sarin exposure. Biochem Pharmacol 2005 0.88
30 Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80. N Engl J Med 2011 0.87
31 Molecular profile and partial functional analysis of novel endothelial cell-derived growth factors that regulate hematopoiesis. Stem Cells 2005 0.86
32 Toxicogenomic studies of the rat brain at an early time point following acute sarin exposure. Neurochem Res 2006 0.84
33 A methodology for utilization of predictive genomic signatures in FFPE samples. BMC Med Genomics 2011 0.80
34 Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival. Int J Hyperthermia 2015 0.78
35 Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587. JAMA 2012 0.77